Stem Cells (National Science Foundation)
BioTime Inc., a biotechnology company in Alameda, California, says that two human embryonic stem (hES) cell lines developed by a subsidiary have been approved by National Institutes of Health (NIH) for the NIH Human Embryonic Stem Cell Registry. Approval by NIH allows the use of these cell lines in federally funded research; only hES cell lines listed in the registry are eligible for federal funding.
NIH created the Human Embryonic Stem Cell Registry in 2001 to encourage research using human embryonic stem cells. The registry now includes hES cell lines that meet certain eligibility criteria including ethical derivation and informed consent.
The company says its two hES lines, ESI-014 and ESI-017, are the first such cell lines approved for Federal funding derived under conditions designed to be compliant with current Good Manufacturing Practices for human clinical use.
As part of a collaboration with the California Institute of Regenerative Medicine (CIRM), BioTime has supplied research grade versions of the cells to dozens of researchers throughout California, including researchers at universities that are part of the University of California system. BioTime has agreed to provide a complete genome sequence to these collaborators by the Fall of 2011 to encourage future human use of products derived from these cell lines.
Read more: Biotech Makes Available Stem Cell Lines to Researchers
* * *
RSS - Posts
[…] cell lines to the Human Embryonic Stem Cell Registry. Two of the company’s hES cell lines are already listed in that registry. All of the lines were developed by Biotime’s subsidiary ES Cell […]